Plus   Neg

Stock Alert: NanoVibronix Shares Up 37% In Pre-Market

Shares of NanoVibronix Inc. (NAOV) are soaring over 37% in pre-market today, after the medical device company announced that the U.S. Centers for Medicare and Medicaid Services or CMS has approved its PainShield for reimbursement for Medicare beneficiaries on a national basis effective January 2020.

PainShield is now available for Medicare reimbursement on a national level under new HCPCS (Healthcare Common Procedure Coding System) code K1004.

PainShield, an ultrasound device, delivers a localized ultrasound effect to treat pain and induce soft tissue healing in a targeted area, while keeping the level of ultrasound energy at a safe and consistent level.

The stock has been trading in the range of $1.50 - $4.50 for the past one year, and closed Tuesday's trade at $2.07, up 12 cents or 6.15%. NAOV is currently trading at $2.84, up 77 cents or 37.20% in the pre-market trading session.

For comments and feedback contact: editorial@rttnews.com

Business News

Follow RTT